Problem 96 - Chemistry: An Atoms-Focused Approach

Question

Are the same radioactive isotopes likely to be used for both imaging and cancer treatment? Why or why not?

Step-by-Step Solution

Answer

Explain why or why not. Answer: No, the same radioactive isotopes are not likely to be used for both imaging and cancer treatment. This is because imaging requires isotopes with short half-lives and low-energy radiation to minimize damage to the patient's healthy tissues, while cancer treatment demands isotopes that emit high-energy radiation capable of killing cancer cells and have a longer half-life to remain active within the tumor for an extended period. Their properties differ to fulfill the specific requirements of medical imaging and cancer treatment.

Step 1: Understand the properties of radioactive isotopes used for imaging

Radioactive isotopes used for imaging purposes, such as PET scans, emit gamma radiation, which can be detected externally. These isotopes have a short half-life which ensures that the radiation dose received by the patient is minimal. Typically isotopes like Fluorine-18, Technetium-99m, and Gallium-67 are used for imaging.

Step 2: Understand the properties of radioactive isotopes used for cancer treatment

Radioactive isotopes used for cancer treatment emit high-energy radiation like alpha or beta particles, which can destroy cancer cells. These isotopes should have a longer half-life so that they remain active within the tumor for a more extended period, increasing the chances of destroying cancer cells. Some commonly used isotopes for cancer treatment include Iodine-131, Radium-223, and Yttrium-90.

Step 3: Compare the properties of isotopes for imaging and cancer treatment

Comparing the properties, we can see that isotopes used for imaging emit gamma radiation and have a short half-life, whereas isotopes used for cancer treatment emit high-energy radiation and have a longer half-life. Thus, the primary difference lies in their emitted radiation type and half-life.

Step 4: Conclusion

In general, the same radioactive isotopes are not likely to be used for both imaging and cancer treatment. This is because imaging requires isotopes with short half-lives and low-energy radiation, ensuring minimal damage to the patient's healthy tissues. In contrast, cancer treatment demands isotopes that emit high-energy radiation capable of killing cancer cells and have a longer half-life to remain active within the tumor for an extended period. Thus, radioactive isotopes differ in their properties to fulfill the specific requirements of medical imaging and cancer treatment.